Area of research
Otorhinolaryngology · Ophthalmology
Research interest
Research interests include Head and Neck Cancer Studies, Glaucoma and retinal disorders, Diabetes Treatment and Management, and Cancer, Lipids, and Metabolism.
Long-term risk of depression after sevoflurane versus propofol anesthesia: a global propensity score-matched cohort study.
Sevoflurane versus propofol and the long-term risk of attention-deficit/hyperactivity disorder in children.
Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes.
GLP-1RAs versus metformin and Parkinson's risk in type 2 diabetes.
N-Acetylcysteine and Dementia Risk in Elderly Patients.
Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.
Metformin Use and Risk of Delirium in Older Adults With Type 2 Diabetes.
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes.
Comparative study of SGLT2 inhibitors and metformin: Evaluating first-line therapies for dementia prevention in type 2 diabetes.
Chronic postsurgical pain increases postoperative depression risk.
Metformin lowers risk of hearing loss and mortality in type 2 diabetes.
Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes.
Fucoidan Improves Tumour Control and Liver Function in TACE for Unresectable Hepatocellular Carcinoma: A Randomised Trial.
Long-term delirium and survival outcomes in patients treated with GLP-1 receptor agonists versus metformin in type 2 diabetes: A population-based cohort study.
SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes.
Sodium-glucose cotransporter-2 inhibitors and subtype-specific dementia risk: A multinational and multiethnic cohort study.
GLP-1 receptor agonists and risk of hepatocellular carcinoma and all-cause mortality in patients with MASLD and type 2 diabetes: a propensity score-matched population-based cohort study.
Metformin's impact on delirium in diabetic cardio surgery patients.
Metformin vs. second-line therapy for delirium prevention in type 2 diabetes: A multinational study.
Statin Use and Reduced Risk of Sudden Sensorineural Hearing Loss in Type 2 Diabetes.
Statins Reduce Delirium Risk in Older Adults With Type 2 Diabetes.
Dexmedetomidine and postoperative dementia risk in older patients.
Metformin use and risk of colorectal cancer in patients with inflammatory bowel disease: a nationwide, population-based cohort study.
Prediction and Screening for Asymptomatic Carotid Artery Stenosis in Post-Radiotherapy Nasopharyngeal Carcinoma Patients
SGLT2is Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head- to-Head Comparative Study.
Impact of perioperative dexmedetomidine on recurrence and survival outcomes in oral cavity squamous cell carcinoma.
Sarcopenia and adverse surgical outcomes following cholecystectomy.
The impact of smoking on postoperative complications following elective off-pump CABG in an ERAS setting.
Impact of Obstructive Sleep Apnea on Outcomes of Minimally Invasive Nasal Surgery for Chronic Rhinitis.
Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction.